Matinas BioPharma | 8-K: Current report
Apr 5 19:03
Matinas BioPharma | 424B5: Prospectus
Apr 5 04:18
Matinas BioPharma | 8-K: Current report
Mar 28 21:04
Matinas BioPharma | 8-K: Current report
Mar 28 04:29
Matinas BioPharma | 10-K: Annual report
Mar 28 04:06
Matinas BioPharma | 8-K: Current report
Mar 25 20:08
Matinas BioPharma | 8-K: Current report
Mar 22 21:22
Matinas BioPharma | 8-K: Current report
Mar 22 18:36
Matinas BioPharma | 8-K: Current report
Feb 26 21:10
Matinas BioPharma | 8-K: Current report
Feb 20 20:38
Matinas BioPharma | 8-K: Current report
Jan 9 13:00
Matinas BioPharma | 8-K: Current report
Dec 27, 2023 13:00
Matinas BioPharma | 8-K: Current report
Dec 21, 2023 20:40
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Matkovits Theresa
Dec 16, 2023 10:46
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Hoover Thomas
Dec 16, 2023 10:46
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Kucinski Keith A
Dec 16, 2023 10:46
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Technology Officer Liu Hui
Dec 16, 2023 10:46
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Jabbour Jerome D
Dec 16, 2023 10:46
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Ferguson James J. III
Dec 16, 2023 10:46
Matinas BioPharma | 8-K: Current report
Nov 20, 2023 20:30
No Data
No Data